US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gene Editing

407.68

+2.870.71%

Number of Gainers:4

Number of Losers:1

Number of Flat:- -

PE:- -

High:414.99

Open:405.38

Low:401.04

Close:404.80

Loading ...

Sangamo Therapeutics Receives Key FDA Designations and Advances Towards 2026 BLA Submission for Fabry Disease Gene Therapy

Sangamo Therapeutics Inc - to Submit Bla in 2026

THOMSON REUTERS

Sangamo Therapeutics Inc - Isaralgagene Civaparvovec Shows Favorable Safety and Tolerability Profile

THOMSON REUTERS

Sangamo Therapeutics Inc - STAAR Study Shows Positive Mean Annualized Egfr Slope at 52 Weeks

THOMSON REUTERS

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease

THOMSON REUTERS

The Best Stocks to Invest $1,000 in Right Now

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

Crispr Therapeutics AG (CRSP) Gets a Hold from Bernstein

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4556/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"Gene Editing","latestPrice":407.67657,"timestamp":1751561999999,"preClose":404.8019,"halted":0,"volume":9910654,"delay":0,"changeRate":0.007101,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":2.874664,"latestTime":"07-03 13:00:00 EDT","open":405.3847,"high":414.9903,"low":401.03595,"amount":158735771.818067,"amplitude":0.034472,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.155526,"peRate":-5.025799,"turnoverRate":0.016885,"increases":4,"decrements":1,"flats":0,"marketCap":7970558912,"floatMarketCap":7697296088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":414.9903,"amplitude":0.034472,"preClose":404.8019,"low":401.03595,"pbRate":"2.155526","latestPrice":407.67657,"volume":9910654,"delay":0,"open":405.3847,"prevYearClose":376.62552,"prevWeekClose":363.1704,"prevMonthClose":368.039,"prevQuarterClose":368.039,"fiveDayClose":361.2085,"twentyDayClose":310.6939,"sixtyDayClose":269.8026,"secType":"PLATE","market":"US","turnoverRate":0.016885,"peRate":-5.025799,"marketCap":7970558912,"floatMarketCap":7697296088,"timestamp":1751561999999,"nameCN":"Gene Editing"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":4,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545794284","title":"Sangamo Therapeutics Receives Key FDA Designations and Advances Towards 2026 BLA Submission for Fabry Disease Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2545794284","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545794284?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:05","pubTimestamp":1750766723,"startTime":"0","endTime":"0","summary":"Sangamo Therapeutics Inc., a genomic medicine company, has announced that its investigational gene therapy, isaralgagene civaparvovec, has received significant regulatory designations from various health authorities. The U.S. Food and Drug Administration  has granted the therapy Orphan Drug, Fast Track, and RMAT designations, while the European Medicines Agency has provided Orphan Medicinal Product designation and PRIME eligibility. Additionally, the U.K. Medicines and Healthcare products Regulatory Agency has included it in the Innovative Licensing and Access Pathway. These designations are expected to expedite the development and potential approval of the therapy, which aims to treat Fabry disease. Sangamo is preparing a Biologics License Application  submission for 2026, following positive results from the Phase 1/2 STAAR study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDL8NJSLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMO","BK4556"],"gpt_icon":0},{"id":"2545847872","title":"Sangamo Therapeutics Inc - to Submit Bla in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2545847872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545847872?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:05","pubTimestamp":1750766700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABNQZ71:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMO","BK4556","BK4139"],"gpt_icon":0},{"id":"2545284784","title":"Sangamo Therapeutics Inc - Isaralgagene Civaparvovec Shows Favorable Safety and Tolerability Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2545284784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545284784?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:05","pubTimestamp":1750766700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABNQZ71:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4556","SGMO","BK4139"],"gpt_icon":0},{"id":"2545284735","title":"Sangamo Therapeutics Inc - STAAR Study Shows Positive Mean Annualized Egfr Slope at 52 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2545284735","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545284735?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:05","pubTimestamp":1750766700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABNQZ71:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4556","BK4139","SGMO"],"gpt_icon":0},{"id":"2545284254","title":"Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2545284254","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545284254?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:05","pubTimestamp":1750766700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABNQZ71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SGMO","BK4556"],"gpt_icon":0},{"id":"2545540695","title":"The Best Stocks to Invest $1,000 in Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2545540695","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545540695?lang=en_us&edition=fundamental","pubTime":"2025-06-24 16:17","pubTimestamp":1750753020,"startTime":"0","endTime":"0","summary":"It's time to look at some names that have been flying under the radar.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/06/24/the-best-stocks-to-invest-1000-in-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4613","BK4588","LU1720051017.SGD","CFLT","BK4524","LU0823421416.USD","BK4532","BK4548","CRSP","LU1804176565.USD","BK4539","LU1548497426.USD","LU0823421333.USD","BK4116","BK4023","LU2357305700.SGD","SHOP","LU2265009873.SGD","BK4585","BK4566","LU0390134368.USD","BK4139","LU1861558580.USD","LU1720051108.HKD","LU1861559042.SGD","BK4528","BK4551","BK4556","BK4611"],"gpt_icon":0},{"id":"2545487315","title":"2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2545487315","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545487315?lang=en_us&edition=fundamental","pubTime":"2025-06-22 06:10","pubTimestamp":1750543800,"startTime":"0","endTime":"0","summary":"These biotech companies have several catalysts ahead -- and in the past have soared on good news.They both offer innovative candidates that could result in game-changing treatments for patients.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/06/21/2-biotech-stocks-to-buy-before-they-soar-84-and-24/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["CRSP","BK4611","LU1861559042.SGD","BK4585","LU1861558580.USD","BK4556","BK4588","BK4139"],"gpt_icon":0},{"id":"2544129166","title":"Crispr Therapeutics AG (CRSP) Gets a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2544129166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544129166?lang=en_us&edition=fundamental","pubTime":"2025-06-20 18:45","pubTimestamp":1750416348,"startTime":"0","endTime":"0","summary":"In a report released yesterday, William Pickering from Bernstein maintained a Hold rating on Crispr Therapeutics AG (CRSP – Research Report). The c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/crispr-therapeutics-ag-crsp-gets-a-hold-from-bernstein-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/crispr-therapeutics-ag-crsp-gets-a-hold-from-bernstein-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4210","BK4588","LU1861558580.USD","BK4556","BK4585","CRSP","AG","BK4611","LU1861559042.SGD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":28,"code":"91000000","status":"200"}]}}